pharmaphorum

AUGUST 10, 2020

While great progress has been made in diseases like diabetes, where HbA1c can be controlled for the majority of patients, we can still improve health outcomes further by providing better monitoring of disease and through more personalised drug delivery.

Genetics 124

Genetics Drug Delivery Research Pharma Companies 124

Drug Discovery World

APRIL 3, 2023

Addressing this need in the market has allowed us penetration to work with 75% of the top twenty pharma companies. Optimer binders are engineered to overcome these problems. This has driven further demand as the industry’s awareness of the technology and capabilities increases.

Antibody 52

Antibody Gene Therapy Gene In-Vitro 52

Delveinsight

FEBRUARY 14, 2021

The health regulatory agencies all over have issued several guidelines, released strategies, and amended regulations to expedite the drug delivery process in the rare disease market landscape.

Marketing 52

Marketing Clinical Trials Clinical Trials Trials 52

pharmaphorum

JUNE 10, 2021

If pharmaceutical companies’ steady price increases are wholly due to limitless greed or thirst for revenue growth, this certainly is not proven by the actual, factual financial results for these same companies. What’s Next: How Should Pharma Companies Respond?

Manufacturing 105

Manufacturing Pharma Companies Drugs Pharmacy 105

Delveinsight

NOVEMBER 29, 2020

Looking at the potential of the pipeline therapies they hold once approved, pharmaceutical companies are charting out a seemingly exciting course in the market. Therapies such as dexamethasone drug delivery system and vascular endothelial growth factor inhibitors have already pierced deeper into the market.

Marketing 52

Marketing Pharma Companies Drug Delivery Clinical Trials 52

XTalks

OCTOBER 1, 2020

Xtalks spoke with WeiQi Lin, MD, PhD, executive vice president, research & development, and principal scientist at DURECT Corporation — a company focused on developing drugs and drug delivery methods in therapeutic areas with significant unmet need — about her transition from academia to industry.

Scientist 52

Scientist In-Vitro Research Life Science 52

pharmaphorum

JULY 9, 2021

Tobacco giant Philip Morris International (PMI) has doubled down on its move into the pharmaceutical sector, following up its recent acquisition of Fertin Pharma with a deal to buy Vectura for around £1 billion ($1.38 The UK pharma company says it has now withdrawn its recommendation to shareholders to accept that deal.

Drug Delivery 52

Drug Delivery Sales Production Drugs 52

Pharmaceutical Technology

MARCH 22, 2023

The injectable drugs market is currently valued at around $532 billion. Yet while demand for injectables soars, regulators are cracking down on quality requirements, forcing many pharma companies to examine the role – and risks – of their primary packaging.

Contamination 130

Contamination Packaging Packaging Manufacturing 130